WCC Biomedical
Latest round
- Series B
Last raised
- Apr 2023
Total raised
- $14M
Investors
- 5
About WCC Biomedical
Founded in 2014 and based in Taiwan, China, WCC Biomedical operates as a health tech company that engages in the research and development of intradermal drug delivery platforms. The company has an operation center in Taipei. Dajiao Liu, the founder of the company, was a senior research scientist at Kodak and a professor at National Tsing Hua University in Taiwan. In 2021, the company joined the Japan External Trade Organization (JETRO). The company changed its name from Wincoat into WCC Biomedical in 2024. The company is mainly engaged in the research and development of intradermal drug delivery platforms and related microneedle patches. The main products include medical microneedle patches, vaccine microneedle patches, medical beauty patches, etc. The independently developed drug delivery platform adopts the multi-layer microneedle platform technology WINMAPTM, which achieves the stability of the needle structure and the control of drug release. The products can be widely used in medical beauty care, medical materials, medicines, vaccines, etc. The company generates revenue by providing intradermal drug delivery platforms and related microneedle patches.
Who invested in WCC Biomedical
5 investors across 1 round
See all investors in WCC Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 30, 2023
Amount
$14M
Investors
Questions about WCC Biomedical
Who invested in WCC Biomedical?
WCC Biomedical has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has WCC Biomedical raised?
WCC Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did WCC Biomedical last raise money?
WCC Biomedical's most recent round on record is a Series B, in Apr 2023.
What does WCC Biomedical do?
Founded in 2014 and based in Taiwan, China, WCC Biomedical operates as a health tech company that engages in the research and development of intradermal drug delivery platforms.
Where is WCC Biomedical headquartered?
WCC Biomedical is headquartered in Hsinchu, Taiwan - China.
Which VCs invest in companies like WCC Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at WCC Biomedical's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like WCC Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.